SCHEMBL2803186

SCHEMBL2803186

CCS(=O)(=O)NC(=O)c1cnn2c(Nc3ccc(F)cc3C)c(C(=O)N3CCC(F)(c4ccc(F)cc4)CC3)cnc12

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FASN P49327 13/20 0.38
SPR P35270 1/20 0.36
ALDH1A1 P00352 3/20 0.35
CBX7 O95931 1/20 0.35
KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2800821 0.96 ALDH1A1 (0.39) FASNALDH1A1CBX7KCNH2
SCHEMBL2802527 0.91 SPR (0.37) FASNSPR
SCHEMBL2800541 0.89 FASN (0.39) FASNSPR
SCHEMBL2802170 0.87 FASN (0.41) FASNALDH1A1
SCHEMBL2800359 0.86 SMN1; SMN2 (0.37) FASNALDH1A1KCNH2
SCHEMBL2803131 0.85 TP53 (0.38) FASNALDH1A1
SCHEMBL2801382 0.85 ALDH1A1 (0.35) ALDH1A1CBX7
SCHEMBL2801107 0.85 FASN (0.39) FASNSPR
SCHEMBL2799803 0.85 PDE4B (0.38) FASNSPRALDH1A1KCNH2
SCHEMBL2801080 0.84 ALDH1A1 (0.36) FASNSPRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206714-B1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO LTD (JP) 2015-01-21 EP disclosed
US-8729264-B2 Agent for prevention and/or treatment of skin diseases KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-05-20 US disclosed
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-10-07 US disclosed
EP-2206714-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES Kyowa Hakko Kirin Co., Ltd. (JP) 2010-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256134-A1 AGENT FOR PREVENTION AND/OR TREATMENT OF SKIN DISEASES TYR, CUTA, SERPINB1 FASN 4286/4885SPR 2955/4885ALDH1A1 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.